share_log

雲頂新耀-B：非執行董事變動

EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR

香港交易所 ·  Jan 12 04:02
Summary by Moomoo AI
雲頂新耀-B（云顶新耀）宣布董事會變動，康嵐女士自2024年1月12日起辭任非執行董事，並無與董事會意見分歧或其他需股東或聯交所關注的事項。同日，曹基哲先生獲委任為非執行董事，曹先生具豐富的醫療保健行業背景，曾任職於CBC集團、再鼎醫藥及花旗集團等。其委任為期三年，期間不會收取薪酬，但可報銷相關費用。董事會對康女士在任期間的貢獻表示感謝，並期待曹先生為公司帶來的新動力。
雲頂新耀-B（云顶新耀）宣布董事會變動，康嵐女士自2024年1月12日起辭任非執行董事，並無與董事會意見分歧或其他需股東或聯交所關注的事項。同日，曹基哲先生獲委任為非執行董事，曹先生具豐富的醫療保健行業背景，曾任職於CBC集團、再鼎醫藥及花旗集團等。其委任為期三年，期間不會收取薪酬，但可報銷相關費用。董事會對康女士在任期間的貢獻表示感謝，並期待曹先生為公司帶來的新動力。
Genting Xinyao B (Genting Xin Yao) announces the change of Board of Directors and Ms. Kang Lan has resigned as a Non-Executive Director effective January 12, 2024, without disagreement with the Board's views or other matters of concern to shareholders or the Exchange. On the same day, Mr. Cao Ki-che was appointed as a non-executive director. Mr. Cao has a rich background in the healthcare industry, having served at CBC Group, Zhao Ding Pharmaceuticals and Citigroup Group, among others. His appointment is for a period of three years and will not be paid, but expenses may be reimbursed. The Board of Directors is grateful for Ms. Kang's contributions during her tenure and looks forward to the new impetus Mr. Cao brings to the Company.
Genting Xinyao B (Genting Xin Yao) announces the change of Board of Directors and Ms. Kang Lan has resigned as a Non-Executive Director effective January 12, 2024, without disagreement with the Board's views or other matters of concern to shareholders or the Exchange. On the same day, Mr. Cao Ki-che was appointed as a non-executive director. Mr. Cao has a rich background in the healthcare industry, having served at CBC Group, Zhao Ding Pharmaceuticals and Citigroup Group, among others. His appointment is for a period of three years and will not be paid, but expenses may be reimbursed. The Board of Directors is grateful for Ms. Kang's contributions during her tenure and looks forward to the new impetus Mr. Cao brings to the Company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more